Loading…

Brexit: does the Windsor Framework help resolve challenges for health?

Solving old problems The EU already acted last year to remove one major immediate source of worry for suppliers and users of medicine in NI—the threat that medicines tested for compliance in GB would not be valid for use.4 Article 3 of the proposed new Regulation will eliminate another: the threat t...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2023-04, Vol.381, p.825-825
Main Authors: Dayan, Mark, Hervey, Tamara, Fleur, Mark
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-b335t-9dcebedfbc0d5b6690df8f727267ed6da93f219e6603c3aaf70cae3ebfe76a003
container_end_page 825
container_issue
container_start_page 825
container_title BMJ (Online)
container_volume 381
creator Dayan, Mark
Hervey, Tamara
Fleur, Mark
description Solving old problems The EU already acted last year to remove one major immediate source of worry for suppliers and users of medicine in NI—the threat that medicines tested for compliance in GB would not be valid for use.4 Article 3 of the proposed new Regulation will eliminate another: the threat that after a grace period ended, suppliers would need to start removing EU security tags and identifiers when a product entered GB, only to reapply new ones when it crossed the Irish Sea.5 A House of Lords Committee recently described this as “the single biggest factor causing difficulties under the Protocol.” Driven by growing divergence in authorisations, which our recent report showed had slowly started to emerge, this was a source of concern among healthcare and medical officials we spoke to, both for cutting-edge drugs and for more inexpensive products where a wide range of suppliers helps guard against price rises and shortages.16 This was the result of NI remaining subject to the approvals system for medicines within the EU’s single market. PE/6/2022/REV/1. https://data.europa.eu/eli/dir/2022/642/oj 5 REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. https://commission.europa.eu/system/files/2023-02/COM_2023_122_1_EN_ACT_part1_v2.pdf 6 Nuffield Trust. (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission
doi_str_mv 10.1136/bmj.p825
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2800147068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2799169408</sourcerecordid><originalsourceid>FETCH-LOGICAL-b335t-9dcebedfbc0d5b6690df8f727267ed6da93f219e6603c3aaf70cae3ebfe76a003</originalsourceid><addsrcrecordid>eNplkE1PwzAMhiMEYtOYxC9AleDApSNp1qTlgmBigDSJC4hjlDYO7UibkrR8_Hs6bQwEJ_vw-LH9InRI8IQQys6yajlpkijeQUPCYxaShNLdX_0Ajb1fYowjypOUxftoQDmeEozJEM2vHHyU7XmgLPigLSB4KmvlrQvmTlbwbt1LUIBpAgfemjcI8kIaA_VzT-ueKkCatrg4QHtaGg_jTR2hx_n1w-w2XNzf3M0uF2FGadyGqcohA6WzHKs4YyzFSieaRzxiHBRTMqU6IikwhmlOpdQc5xIoZBo4kxjTETpdextnXzvwrahKn4MxsgbbeREl_VdTjlnSo8d_0KXtXN1fJyKepoSlU5z8CHNnvXegRePKSrpPQbBYxSv6eMUq3h492gi7rAK1Bb_D7IGTNbAa2S775_kCxzKBMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799169408</pqid></control><display><type>article</type><title>Brexit: does the Windsor Framework help resolve challenges for health?</title><source>BMJ Journals</source><creator>Dayan, Mark ; Hervey, Tamara ; Fleur, Mark</creator><creatorcontrib>Dayan, Mark ; Hervey, Tamara ; Fleur, Mark</creatorcontrib><description>Solving old problems The EU already acted last year to remove one major immediate source of worry for suppliers and users of medicine in NI—the threat that medicines tested for compliance in GB would not be valid for use.4 Article 3 of the proposed new Regulation will eliminate another: the threat that after a grace period ended, suppliers would need to start removing EU security tags and identifiers when a product entered GB, only to reapply new ones when it crossed the Irish Sea.5 A House of Lords Committee recently described this as “the single biggest factor causing difficulties under the Protocol.” Driven by growing divergence in authorisations, which our recent report showed had slowly started to emerge, this was a source of concern among healthcare and medical officials we spoke to, both for cutting-edge drugs and for more inexpensive products where a wide range of suppliers helps guard against price rises and shortages.16 This was the result of NI remaining subject to the approvals system for medicines within the EU’s single market. PE/6/2022/REV/1. https://data.europa.eu/eli/dir/2022/642/oj 5 REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. https://commission.europa.eu/system/files/2023-02/COM_2023_122_1_EN_ACT_part1_v2.pdf 6 Nuffield Trust. (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission</description><identifier>ISSN: 1756-1833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.p825</identifier><identifier>PMID: 37041001</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Councils ; Diffusion Magnetic Resonance Imaging ; EU membership ; European Union ; Food ; Humans ; Labeling ; Opinion ; Parliaments ; Politics ; Regulation ; Regulatory agencies ; Suppliers ; United Kingdom</subject><ispartof>BMJ (Online), 2023-04, Vol.381, p.825-825</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b335t-9dcebedfbc0d5b6690df8f727267ed6da93f219e6603c3aaf70cae3ebfe76a003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://bmj.com/content/381/bmj.p825.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://bmj.com/content/381/bmj.p825.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>314,780,784,3194,27924,27925,55341,77596,77597</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37041001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dayan, Mark</creatorcontrib><creatorcontrib>Hervey, Tamara</creatorcontrib><creatorcontrib>Fleur, Mark</creatorcontrib><title>Brexit: does the Windsor Framework help resolve challenges for health?</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><addtitle>BMJ</addtitle><description>Solving old problems The EU already acted last year to remove one major immediate source of worry for suppliers and users of medicine in NI—the threat that medicines tested for compliance in GB would not be valid for use.4 Article 3 of the proposed new Regulation will eliminate another: the threat that after a grace period ended, suppliers would need to start removing EU security tags and identifiers when a product entered GB, only to reapply new ones when it crossed the Irish Sea.5 A House of Lords Committee recently described this as “the single biggest factor causing difficulties under the Protocol.” Driven by growing divergence in authorisations, which our recent report showed had slowly started to emerge, this was a source of concern among healthcare and medical officials we spoke to, both for cutting-edge drugs and for more inexpensive products where a wide range of suppliers helps guard against price rises and shortages.16 This was the result of NI remaining subject to the approvals system for medicines within the EU’s single market. PE/6/2022/REV/1. https://data.europa.eu/eli/dir/2022/642/oj 5 REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. https://commission.europa.eu/system/files/2023-02/COM_2023_122_1_EN_ACT_part1_v2.pdf 6 Nuffield Trust. (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission</description><subject>Councils</subject><subject>Diffusion Magnetic Resonance Imaging</subject><subject>EU membership</subject><subject>European Union</subject><subject>Food</subject><subject>Humans</subject><subject>Labeling</subject><subject>Opinion</subject><subject>Parliaments</subject><subject>Politics</subject><subject>Regulation</subject><subject>Regulatory agencies</subject><subject>Suppliers</subject><subject>United Kingdom</subject><issn>1756-1833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNplkE1PwzAMhiMEYtOYxC9AleDApSNp1qTlgmBigDSJC4hjlDYO7UibkrR8_Hs6bQwEJ_vw-LH9InRI8IQQys6yajlpkijeQUPCYxaShNLdX_0Ajb1fYowjypOUxftoQDmeEozJEM2vHHyU7XmgLPigLSB4KmvlrQvmTlbwbt1LUIBpAgfemjcI8kIaA_VzT-ueKkCatrg4QHtaGg_jTR2hx_n1w-w2XNzf3M0uF2FGadyGqcohA6WzHKs4YyzFSieaRzxiHBRTMqU6IikwhmlOpdQc5xIoZBo4kxjTETpdextnXzvwrahKn4MxsgbbeREl_VdTjlnSo8d_0KXtXN1fJyKepoSlU5z8CHNnvXegRePKSrpPQbBYxSv6eMUq3h492gi7rAK1Bb_D7IGTNbAa2S775_kCxzKBMg</recordid><startdate>20230411</startdate><enddate>20230411</enddate><creator>Dayan, Mark</creator><creator>Hervey, Tamara</creator><creator>Fleur, Mark</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20230411</creationdate><title>Brexit: does the Windsor Framework help resolve challenges for health?</title><author>Dayan, Mark ; Hervey, Tamara ; Fleur, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b335t-9dcebedfbc0d5b6690df8f727267ed6da93f219e6603c3aaf70cae3ebfe76a003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Councils</topic><topic>Diffusion Magnetic Resonance Imaging</topic><topic>EU membership</topic><topic>European Union</topic><topic>Food</topic><topic>Humans</topic><topic>Labeling</topic><topic>Opinion</topic><topic>Parliaments</topic><topic>Politics</topic><topic>Regulation</topic><topic>Regulatory agencies</topic><topic>Suppliers</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dayan, Mark</creatorcontrib><creatorcontrib>Hervey, Tamara</creatorcontrib><creatorcontrib>Fleur, Mark</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dayan, Mark</au><au>Hervey, Tamara</au><au>Fleur, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brexit: does the Windsor Framework help resolve challenges for health?</atitle><jtitle>BMJ (Online)</jtitle><stitle>BMJ</stitle><addtitle>BMJ</addtitle><date>2023-04-11</date><risdate>2023</risdate><volume>381</volume><spage>825</spage><epage>825</epage><pages>825-825</pages><issn>1756-1833</issn><eissn>1756-1833</eissn><abstract>Solving old problems The EU already acted last year to remove one major immediate source of worry for suppliers and users of medicine in NI—the threat that medicines tested for compliance in GB would not be valid for use.4 Article 3 of the proposed new Regulation will eliminate another: the threat that after a grace period ended, suppliers would need to start removing EU security tags and identifiers when a product entered GB, only to reapply new ones when it crossed the Irish Sea.5 A House of Lords Committee recently described this as “the single biggest factor causing difficulties under the Protocol.” Driven by growing divergence in authorisations, which our recent report showed had slowly started to emerge, this was a source of concern among healthcare and medical officials we spoke to, both for cutting-edge drugs and for more inexpensive products where a wide range of suppliers helps guard against price rises and shortages.16 This was the result of NI remaining subject to the approvals system for medicines within the EU’s single market. PE/6/2022/REV/1. https://data.europa.eu/eli/dir/2022/642/oj 5 REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. https://commission.europa.eu/system/files/2023-02/COM_2023_122_1_EN_ACT_part1_v2.pdf 6 Nuffield Trust. (EU) No 609/2013 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>37041001</pmid><doi>10.1136/bmj.p825</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-1833
ispartof BMJ (Online), 2023-04, Vol.381, p.825-825
issn 1756-1833
1756-1833
language eng
recordid cdi_proquest_miscellaneous_2800147068
source BMJ Journals
subjects Councils
Diffusion Magnetic Resonance Imaging
EU membership
European Union
Food
Humans
Labeling
Opinion
Parliaments
Politics
Regulation
Regulatory agencies
Suppliers
United Kingdom
title Brexit: does the Windsor Framework help resolve challenges for health?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A58%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brexit:%20does%20the%20Windsor%20Framework%20help%20resolve%20challenges%20for%20health?&rft.jtitle=BMJ%20(Online)&rft.au=Dayan,%20Mark&rft.date=2023-04-11&rft.volume=381&rft.spage=825&rft.epage=825&rft.pages=825-825&rft.issn=1756-1833&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.p825&rft_dat=%3Cproquest_cross%3E2799169408%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b335t-9dcebedfbc0d5b6690df8f727267ed6da93f219e6603c3aaf70cae3ebfe76a003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2799169408&rft_id=info:pmid/37041001&rfr_iscdi=true